Adaptive Immune Response

Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers
Muhammad Umair Mushtaq, Athanasios Papadas, Adam Pagenkopf, Evan Flietner, Zachary Morrow, Sibgha Gull Chaudhary, Fotis Asimakopoulos

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 65; DOI: 10.1186/s40425-018-0376-0
Tumor control by intravenous administration of STING ligand requires combination with precisely timed radiation therapy
Jason Baird, David Friedman, Benjamin Cottam, Marka Crittenden, Michael Gough

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P349; DOI: 10.1186/2051-1426-3-S2-P349
The mAbXcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-CTLA4 antibody
Isabelle Sansal-Castellano, Mark Carlson, Gabriel Reznik, James Siedlecki, John Kane, Zuzana Dostalova, Hua Miao, Ifat Rubin-Bejerano

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P414; DOI: 10.1186/2051-1426-3-S2-P414
Anti-EGFR targeted monoclonal antibody isotype influences anti-tumor immunity in head and neck cancer patients
Sumita Trivedi, Raghvendra M Srivastava, Fernando Concha-Benavente, Tatiana M Garcia-Bates, Jing Li, Robert L Ferris

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P316; DOI: 10.1186/2051-1426-3-S2-P316
Identification of continued challenges and opportunities in oncologists' comprehension of immuno-oncology
Tara Herrmann, Frieda Pearce, Charlotte Warren, Haleh Kadkhoda, Lianne Wiggins, Andrea Rindo

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P135; DOI: 10.1186/2051-1426-3-S2-P135
Current clinical challenges and opportunities in oncologists' familiarity and understanding of immuno-oncology
Tara Herrmann, Charlotte Warren

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P180; DOI: 10.1186/2051-1426-2-S3-P180
Intratumoral injection of STING ligand promotes abscopal effect
Jason R Baird, Thomas W Dubensky, David B Kanne, David J Friedman, Benjamin Cottam, Shelly Bambina, Keith S Bahjat, Marka Crittenden, Michael Gough

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P158; DOI: 10.1186/2051-1426-2-S3-P158
HLA-G-specific microRNAs a novel approach for targeting tumors
Simon Jasinski-Bergner, Arndt Hartmann, Verena Spath, Stefan Huettelmaier, Juliane Braun, Juergen Bukur, Barbara Seliger

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P174; DOI: 10.1186/2051-1426-1-S1-P174
S49. Clinical activity and development of biomarkers for an engineered anti PDL1 antibody MPDL3280A
E Cha

Journal for ImmunoTherapy of Cancer Mar 2014, 2 (Suppl 2) I21; DOI: 10.1186/2051-1426-2-S2-I21

Log in using your username and password

Main menu

Log in using your username and password

You are here

Adaptive Immune Response